Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Revenue (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Revenue for 6 consecutive years, with $11.3 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 37.28% to $11.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.6 million through Dec 2025, up 19.74% year-over-year, with the annual reading at $33.6 million for FY2025, 19.74% up from the prior year.
  • Revenue hit $11.3 million in Q4 2025 for Rapid Micro Biosystems, up from $7.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $11.3 million in Q4 2025 to a low of $3.9 million in Q2 2022.
  • Historically, Revenue has averaged $6.2 million across 5 years, with a median of $6.1 million in 2021.
  • Biggest five-year swings in Revenue: surged 136.41% in 2021 and later tumbled 37.03% in 2022.
  • Year by year, Revenue stood at $5.2 million in 2021, then decreased by 16.01% to $4.4 million in 2022, then skyrocketed by 44.88% to $6.3 million in 2023, then rose by 29.68% to $8.2 million in 2024, then skyrocketed by 37.28% to $11.3 million in 2025.
  • Business Quant data shows Revenue for RPID at $11.3 million in Q4 2025, $7.8 million in Q3 2025, and $7.3 million in Q2 2025.